Controlling the Narrative in Medtech

Nicole Osmer, Health+Commerce’s founder and CEO, joins Let’s Talk Medtech to discuss how medical device companies can build successful brand strategies.

Omar Ford

May 6, 2022

1 Min Read
IMG_2022-5-5-123922.jpg
Image courtesy of Health+Commerce

Something remarkable is happening in the medtech industry. Medical devices are becoming more mainstream. Patients are now becoming “consumers.” Companies have even advertised during the Superbowl in an attempt to make devices a household name.

With this change, companies must rethink marketing and communication efforts surrounding their products.

Nicole Osmer, CEO and founder of Health+Commerce joins us for this episode of Let’s Talk Medtech to give companies tips on how to better communicate ideas surrounding devices.

Osmer said Health+Commerce helps large and small companies cut through the communication clutter and create strong strategies going forward.  

“What we do is help set strategy,” Osmer said during the Let’s Talk Medtech interview. “We ask the company to provide us with the upcoming milestones for the next usually 12 months and then put together a plan for them outlining how we will approach each of those milestones and what will do to fill in the gaps. Especially, early-stage companies don't always have a lot of news flow. That’s where we bring in our digital team, social media [team] to think about what else can we do to help.”

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like